Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023&ndas
by from Morbidity and Mortality Weekly Report (MMWR) on (#6S7KB)
This report describes nirsevimab effectiveness in preventing RSV-associated hospitalizations among children in Alaska's Yukon-Kuskokwim Delta region.